MGMT Promoter Methylation and IDH1 Mutation Testing to Prognosticate Glioblastoma Multiforme and Determine Alkylating Agent Treatment Eligibility: KHCC Experience
JOURNAL OF MOLECULAR DIAGNOSTICS（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要